Medtronic, Inc. has the FDA’s approval to initiate the Feasibility of the Lone Atrial Fibrillation Clinical Trial (FACT) ...
An initial review of the premarket approval application for the ATS 3f(R) Aortic Bioprosthesis Heart Valve has been ...
Thoratec has announced it has filed the first two modules of its Pre-Market Approval to market its HeartMate II for ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
The first patient of the PATRIOT (Peripheral Approach To Recanalization In Occluded Totals) U.S. pivotal study has been ...
New tachycardia software for the Merlin Patient Care System by St. Jude Medical has received FDA approval. The software ...
The American College of Cardiology Foundation’s National Cardiovascular Data Registry (NCDR) says it will launch a new ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
San Francisco-based McKesson announced it has agreed to purchase Per-Se Technologies, Alpharetta, Ga., in a deal worth $1.8 billion. The purchase is expected to close in the first quarter of 2007 if it meets regulatory approval.
Stereotaxis has received FDA 510(k) clearance for its Niobe magnetic navigation system for use in neurovascular and ...
An aspirin a day really does keep heart attack and stroke away for women, yet fewer than half of American women who could benefit from the simple measure do not take a daily pill, according to recent research.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
The FDA has cleared Boston Scientific’s NexStent Carotid Stent and Monorail Delivery System for use in patients with ...
The FDA has approved NitroMist (Nitroglycerin Lingual Aerosol) for acute relief of an attack or acute prophylaxis of ...
Washington University surgeons at Barnes-Jewish Hospital, St. Louis, began training at UMC in Tucson on Nov. 2 to become ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Results from the Phase II MEND-CABG study — which looked at demonstrated the clinical benefits of MC-1 in reducing ...
A new study published in the Oct. 30 edition of “Circulation” calls the onset of peripheral arterial disease (PAD) among ...
Hospitals and other medical facilities across the state of Washington will receive $1 million in grant money allocated ...
November 09, 2006
